In ₹ Crore except Per Share Latest Annual	NECLIFE FY26	AAREYDRUGS FY26	NATCAPSUQ FY26	MEDICAMEQ FY26	Peer Average
Valuation — at last close
P/E	—	77.73×	—	◆ 35.21×	56.47×
P/B	◆ 0.35×	2.04×	0.64×	1.25×	1.31× -74%
EV/EBITDA	-1.25×	49.64×	◆ -169.48×	18.31×	-33.84× +96%
Market Cap	₹201 Cr	₹307 Cr	₹142 Cr	₹345 Cr	₹265 Cr -24%
Growth
Revenue CAGR 3Y	-81.73%	◆ 96.26%	—	11.97%	54.12% -251%
Revenue CAGR 5Y	-64.04%	—	—	—	—
Net Income CAGR 3Y	—	◆ 100.20%	—	-12.71%	43.75%
Revenue YoY (latest Q)	-99.99%	-56.34%	7.76%	◆ 11.27%	-12.44% -704%
Net Income YoY (latest Q)	◆ 75.65%	-25.36%	-2.93%	15.35%	-4.31% +1854%
Profitability
EBITDA Margin	—	1.52%	-0.83%	◆ 9.90%	3.53%
Net Income Margin	-3152.45%	0.84%	-13.17%	◆ 4.95%	-2.46% -128048%
Return on Common Equity	-38.08%	2.75%	-7.51%	◆ 3.95%	-0.27% -14004%
Return on Capital Employed	-7.53%	2.94%	-6.12%	◆ 4.92%	0.58% -1398%
Return on Assets	-21.95%	1.48%	-5.85%	◆ 2.93%	-0.48% -4473%
Credit & Quality
Total Debt/Equity	◆ 0.00×	0.33×	0.49×	0.17×	0.33× -100%
Interest Coverage	-1.69×	0.86×	-1.71×	◆ 3.54×	0.90× -288%
Scale — latest FY
Revenue / Total Income	₹0 Cr	₹472 Cr	₹187 Cr	₹198 Cr	₹286 Cr -100%
Net Income	−₹293 Cr	₹4 Cr	−₹24.7 Cr	₹9.8 Cr	−₹3.6 Cr -7962%
Total Assets	₹622 Cr	₹297 Cr	₹424 Cr	₹372 Cr	₹364 Cr +71%
EPS	₹-13.4	₹1.39	₹-23.84	₹7.22	₹-5.08 -164%
Book Value per Share	₹29.97	₹52.86	₹213.39	₹203.17	₹156.47 -81%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.